ENHANCEMENT OF ANTIBODY-RESPONSES TO INFLUENZA-B VIRUS HEMAGGLUTININ BY USE OF A NEW ADJUVANT FORMULATION

被引：36

作者：

BYARS, NE ^{[1
]}

ALLISON, AC ^{[1
]}

HARMON, MW ^{[1
]}

KENDAL, AP ^{[1
]}

机构：

[1] CTR DIS CONTROL, CTR INFECT DIS, DIV VIRAL DIS, INFLUENZA BRANCH, ATLANTA, GA 30333 USA

来源：

VACCINE | 1990年 / 8卷 / 01期

关键词：

adjuvant; antibody response; Influenza B virus haemagglutinin;

D O I：

10.1016/0264-410X(90)90177-N

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mice and guinea pigs were immunized with the haemagglutinin (HA) of influenza B-USSR/100 virus, either in Syntex Adjuvant Formulation-1 (SAF-1) or in saline. Antibody titres were determined by ELISA, haemagglutination inhibition and virus neutralization. Animals immunized with HA in SAF-1 had significantly higher antibody titres than did animals immunized with HA in saline. Both 3-week-old and 13 1 2-month-old mice had greater and more uniform antibody responses to HA in SAF-1 than to HA in saline. © 1990.

引用

页码：49 / 56

页数：8

共 34 条

[1] A STUDY OF EXCESS MORTALITY DURING INFLUENZA EPIDEMICS IN THE UNITED-STATES, 1968-1976
ALLING, DW
BLACKWELDER, WC
STUARTHARRIS, CH
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 113 (01) : 30 - 43
[2] ALLISON AC, 1980, VIRAL ONCOLOGY, P481
[3] SAFETY AND IMMUNOGENICITY OF A 45-MU-G SUPPLEMENTAL DOSE OF INACTIVATED SPLIT-VIRUS INFLUENZA-B VACCINE IN THE ELDERLY
ARDEN, NH
PATRIARCA, PA
LUI, KJ
HARMON, MW
BRANDON, F
KENDAL, AP
[J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (04) : 805 - 806
[4] ARDEN NH, 1986, OPTIONS CONTROL INFL, P155
[5] AUDIBERT F, 1977, CR ACAD SCI D NAT, V285, P467
[6] PNEUMONIA AND INFLUENZA DEATHS DURING EPIDEMICS - IMPLICATIONS FOR PREVENTION
BARKER, WH
MULLOOLY, JP
[J]. ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (01) : 85 - 89
[7] INFLUENZA VACCINATION OF ELDERLY PERSONS - REDUCTION IN PNEUMONIA AND INFLUENZA HOSPITALIZATIONS AND DEATHS
BARKER, WH
MULLOOLY, JP
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (22): : 2547 - 2549
[8] ADJUVANT FORMULATION FOR USE IN VACCINES TO ELICIT BOTH CELL-MEDIATED AND HUMORAL IMMUNITY
BYARS, NE
ALLISON, AC
[J]. VACCINE, 1987, 5 (03) : 223 - 228
[9] DAVENPORT FM, 1968, ANN ALLERGY, V26, P288
[10] Dowdle WR, 1979, DIAGNOSTIC PROCEDURE, P585

← 1 2 3 4 →